Información del producto
Nombre:SR9011
Producto controlado
Marca:Biosynth
Descripción:SR9011 is a small-molecule drug that has been shown to have anti-cancer effects. It is currently undergoing clinical trials for the treatment of cancer, including glioblastoma (brain cancer) and non-small cell lung cancer. SR9011 inhibits the activation of microglia cells in the brain, which are associated with neurological disorders such as Alzheimer's disease and Parkinson's disease. This drug also reduces skin inflammation and can be used to treat inflammatory diseases such as Crohn's disease or ulcerative colitis. SR9011 can also be used to treat metabolic disorders, such as type 2 diabetes or obesity. The mechanism of action for SR9011 is not fully understood, but it has been shown to activate autophagy in human liver cells and beta-cells in the pancreas.SR9011 was originally developed by Sirtris Pharmaceuticals under the code name "SR9009."
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:479.04 g/mol
Fórmula:C23H31ClN4O3S
Pureza:Min. 95%
Consulta técnica sobre: SR9011
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.